<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Farid A</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>This study aims to assess the bactericidal efficacy of Multilevel Antimicrobial Polymer (MAP-1) on standard bedsheets in Long-term care facility (LTCF). The research quantifies total viable bacteria and MRSA counts and evaluates the percentage difference between treated and control bedding material over a one-week period.&lt;h4>Design&lt;/h4>A double-blind interventional, double cross-over study.&lt;h4>Setting&lt;/h4>Haven of Hope Woo Ping Care and Attention Home in Sai Kung, Hong Kong.&lt;h4>Methods&lt;/h4&gt;Over an 8-week period, bedding materials from residents' rooms were sampled, totalling 288 samples from 96 bedsheets, with half treated with MAP-1 and the remaining serving as controls. MAP-1, developed at The Hong Kong University of Science and Technology, incorporates USFDA and USEPA-</pubmed_abstract><journal>Antimicrobial resistance and infection control</journal><pagination>36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12020249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Enhancing bedding hygiene in long-term care facilities: investigating the impact of multilevel antimicrobial polymers (MAP-1) on bacterial and MDRO reduction.</pubmed_title><pmcid>PMC12020249</pmcid><pubmed_authors>Farid A</pubmed_authors><pubmed_authors>Han W</pubmed_authors><pubmed_authors>Kwan JKC</pubmed_authors><pubmed_authors>Yeung KL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enhancing bedding hygiene in long-term care facilities: investigating the impact of multilevel antimicrobial polymers (MAP-1) on bacterial and MDRO reduction.</name><description>&lt;h4>Objective&lt;/h4>This study aims to assess the bactericidal efficacy of Multilevel Antimicrobial Polymer (MAP-1) on standard bedsheets in Long-term care facility (LTCF). The research quantifies total viable bacteria and MRSA counts and evaluates the percentage difference between treated and control bedding material over a one-week period.&lt;h4>Design&lt;/h4>A double-blind interventional, double cross-over study.&lt;h4>Setting&lt;/h4>Haven of Hope Woo Ping Care and Attention Home in Sai Kung, Hong Kong.&lt;h4>Methods&lt;/h4&gt;Over an 8-week period, bedding materials from residents' rooms were sampled, totalling 288 samples from 96 bedsheets, with half treated with MAP-1 and the remaining serving as controls. MAP-1, developed at The Hong Kong University of Science and Technology, incorporates USFDA and USEPA-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-06T03:04:27.907Z</modification><creation>2025-07-06T03:04:27.907Z</creation></dates><accession>S-EPMC12020249</accession><cross_references><pubmed>40270052</pubmed><doi>10.1186/s13756-025-01555-0</doi></cross_references></HashMap>